McKesson Corporation (MCK): Price and Financial Metrics


McKesson Corporation (MCK)

Today's Latest Price: $152.00 USD

0.25 (0.16%)

Updated Aug 7 12:00am

Add MCK to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 68 in Medical - Services

See all "A" rated Strong Buy stocks

MCK Stock Summary

  • Mckesson Corp's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than 99.23% of US listed stocks.
  • With a price/sales ratio of 0.11, Mckesson Corp has a higher such ratio than only 3.73% of stocks in our set.
  • In terms of volatility of its share price, MCK is more volatile than just 2.91% of stocks we're observing.
  • If you're looking for stocks that are quantitatively similar to Mckesson Corp, a group of peers worth examining would be LOW, SUMR, AFH, RAD, and JWN.
  • MCK's SEC filings can be seen here. And to visit Mckesson Corp's official web site, go to www.mckesson.com.
MCK Daily Price Range
MCK 52-Week Price Range

MCK Stock Price Chart Technical Analysis Charts


MCK Price/Volume Stats

Current price $152.00 52-week high $172.18
Prev. close $151.75 52-week low $112.60
Day low $150.73 Volume 569,000
Day high $152.11 Avg. volume 2,971,790
50-day MA $153.63 Dividend yield 1.08%
200-day MA $145.65 Market Cap 24.65B

McKesson Corporation (MCK) Company Bio


Mckesson Corporation partners with payers, hospitals, physician offices, pharmacies, pharmaceutical companies and others across the spectrum of care to build healthier organizations that deliver better care to patients in every setting. McKesson helps its customers improve their financial, operational, and clinical performance with solutions that include pharmaceutical and medical-surgical supply management, healthcare information technology, and business and clinical services. The company was founded in 1833 and is based in San Francisco, California.

MCK Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$152.00$242.93 58%

The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Mckesson Corp. To summarize, we found that Mckesson Corp ranked in the 58th percentile in terms of potential gain offered. Specifically, our DCF analysis implies the stock is trading below its fair value by an estimated 59%. The most interesting components of our discounted cash flow analysis for Mckesson Corp ended up being:

  • Mckesson Corp's weighted average cost of capital (WACC) is 7%; for context, that number is higher than only 14.53% of tickers in our DCF set.
  • Relative to other stocks in its sector (Healthcare), Mckesson Corp has a reliance on debt greater than 67.6% of them.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%55%
1%57%
2%58%
3%60%
4%61%
5%63%

For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as MCK, try RSCF, QDEL, UHS, PBH, and UNH.





MCK Latest News Stream


Event/Time News Detail
Loading, please wait...

MCK Latest Social Stream


Loading social stream, please wait...

View Full MCK Social Stream

Latest MCK News From Around the Web

Below are the latest news stories about Mckesson Corp that investors may wish to consider to help them evaluate MCK as an investment opportunity.

McKesson (MCK) to Post Q1 Earnings: What's in the Offing?

McKesson's (MCK) fiscal first-quarter results are likely to reflect solid show by U.S. Pharmaceutical and Specialty Solutions segment.

Yahoo | July 30, 2020

McKesson Declares Quarterly Dividend July 29, 2020

IRVING, Texas--(BUSINESS WIRE)--The Board of Directors of McKesson Corporation (NYSE:MCK) today declared a regular dividend of 42 cents per share of common stock. The dividend will be payable on October 1, 2020, to stockholders of record on September 1, 2020. About McKesson Corporation McKesson Corporation is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. McKesson partners with pharm

Business Wire | July 29, 2020

FPA Capital Fund Buys 1, Trims 4 Positions in the 2nd Quarter

Los Angeles-based fund slashes holdings in several companies Continue reading...

Yahoo | July 22, 2020

McKesson Named One of the Best Places to Work for Disability Inclusion

IRVING, Texas--(BUSINESS WIRE)--McKesson today announced that The Disability Equality Index (DEI) has named the company as one of its 2020 Best Places to Work for Disability Inclusion with a top-ranking score of 100. This is the fifth year in a row that McKesson has been recognized by the DEI as a top place to work and the second year in a row earning a top score. “We are pleased to once again be recognized by The Disability Equality Index as one of the best places to work for disability inclus

Business Wire | July 16, 2020

Here's Why You Should Retain McKesson (MCK) Stock for Now

McKesson (MCK) continues to benefit from multi-year strategic growth initiative and Distribution Solutions segment.

Yahoo | July 15, 2020

Read More 'MCK' Stories Here

MCK Price Returns

1-mo 6.28%
3-mo 8.65%
6-mo -7.18%
1-year 9.64%
3-year 3.96%
5-year -26.16%
YTD 10.48%
2019 26.72%
2018 -28.40%
2017 11.95%
2016 -28.30%
2015 -4.51%

MCK Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full MCK Dividend History

Continue Researching MCK

Here are a few links from around the web to help you further your research on Mckesson Corp's stock as an investment opportunity:

Mckesson Corp (MCK) Stock Price | Nasdaq
Mckesson Corp (MCK) Stock Quote, History and News - Yahoo Finance
Mckesson Corp (MCK) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.9056 seconds.